William A. Nahhas

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.

David S. Alberts, S Green, Edward V. Hannigan et al. · Journal of Clinical Oncology · 1992 · 299 citations

Analysis of factors contributing to treatment failures in Stages IB and IIA carcinoma of the cervix

C.K. Chung, William A. Nahhas, John A. Stryker et al. · American Journal of Obstetrics and Gynecology · 1980 · 196 citations

Cervical Cancer Management, Cervical Cancer, Medicine +10

The preservation of ovarian function in young women undergoing pelvic radiation therapy

Nader Husseinzadeh, William A. Nahhas, Donald E. Velkley et al. · Gynecologic Oncology · 1984 · 93 citations

Hormonal Contraceptive, Fertility, Pelvic Radiation Therapy +11

A Dose-Escalating Study of Weekly Bolus Topotecan in Previously Treated Ovarian Cancer Patients

Howard D. Homesley, Don Hall, George Lewandowski et al. · Gynecologic Oncology · 2001 · 82 citations

Medicine, Dose-escalating Study, Metronomic Therapy +7

Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities.

David R. Gandara, William A. Nahhas, Mark Adelson et al. · Journal of Clinical Oncology · 1995 · 70 citations